Savarino V, Mela G S, Zentilin P, Cutela P, Mele M R, Vigneri S, Celle G
Dipartimento di Medicina Interna, Università di Genova, Italy.
Dig Dis Sci. 1994 Jan;39(1):161-8. doi: 10.1007/BF02090077.
This study was carried out in order to perform a combined prospective assessment of the individual pharmacodynamic response and of duodenal ulcer healing in patients treated with three different doses of omeprazole. Ninety-nine patients with endoscopically proven duodenal ulcers were subdivided into three parallel groups of 33 cases, who were randomly assigned to receive orally at 0800 hr, in single blind fashion, either 10 mg, 20 mg, or 40 mg of omeprazole. All of them underwent continuous intragastric pH monitoring both in basal conditions and on the fifth day of each dose regimen; ulcer healing was then assessed endoscopically after four weeks of treatment. All three doses of omeprazole caused pH values to increase significantly (P < 0.001) over the whole 24-hr period. In patients treated with omeprazole 10 mg, the individual responses showed the highest variability: the acid inhibition, expressed in terms of time spent above pH 3.0, lasted for more than 16 hr in 42% of cases, for more than 8 hr in 28%, and for less than 6 hr in 30%. In patients treated with omeprazole 20 mg, the pharmacological response was more marked and uniform and lasted for more than 16 hr in 79% of cases; however, it is worth noting it lasted for less than 6 hr in three patients (10%). In patients treated with omeprazole 40 mg, the individual response was excellent (more than 16 hr) in 94% of cases, and it lasted for less than 6 hr in only one patient (3%).(ABSTRACT TRUNCATED AT 250 WORDS)
本研究旨在对接受三种不同剂量奥美拉唑治疗的患者的个体药效学反应和十二指肠溃疡愈合情况进行联合前瞻性评估。99例经内镜证实为十二指肠溃疡的患者被分为三组,每组33例,随机分配在08:00时以单盲方式口服10毫克、20毫克或40毫克奥美拉唑。所有患者在基础状态和每种剂量方案的第五天均接受连续胃内pH监测;治疗四周后通过内镜评估溃疡愈合情况。所有三种剂量的奥美拉唑均使24小时内的pH值显著升高(P < 0.001)。接受10毫克奥美拉唑治疗的患者,个体反应差异最大:以pH值高于3.0的时间表示的酸抑制作用,42%的病例持续超过16小时,28%的病例持续超过8小时,30%的病例持续少于6小时。接受20毫克奥美拉唑治疗的患者,药理反应更显著且更一致,79%的病例持续超过16小时;然而,值得注意的是,有三名患者(10%)持续时间少于6小时。接受40毫克奥美拉唑治疗的患者,94%的病例个体反应良好(超过16小时),只有一名患者(3%)持续时间少于6小时。(摘要截断于250字)